The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats.

J Cell Mol Med · 2008 · PMC3918085 · PMID 18194463

Europe PMC DOI

hedged sentence

0.1800

closest p · 3.6× alpha

0.1800

boldest claim

The sentences

did not reach statistical significanceP = 0.18not close (p > 0.1)

Octreotide decreased the extent of collateral formation by 16% after 4 days of treatment compared with vehicle-treated portal hypertensive rats, but the difference did not reach statistical significance (P = 0.18).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.